These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 17133207)

  • 1. Practical and conceptual challenges in measuring antiretroviral adherence.
    Berg KM; Arnsten JH
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1(Suppl 1):S79-87. PubMed ID: 17133207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving antiretroviral therapy adherence in resource-limited settings at scale: a discussion of interventions and recommendations.
    Haberer JE; Sabin L; Amico KR; Orrell C; Galárraga O; Tsai AC; Vreeman RC; Wilson I; Sam-Agudu NA; Blaschke TF; Vrijens B; Mellins CA; Remien RH; Weiser SD; Lowenthal E; Stirratt MJ; Sow PS; Thomas B; Ford N; Mills E; Lester R; Nachega JB; Bwana BM; Ssewamala F; Mbuagbaw L; Munderi P; Geng E; Bangsberg DR
    J Int AIDS Soc; 2017; 20(1):21371. PubMed ID: 28630651
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjusting and censoring electronic monitoring device data. Implications for study outcomes.
    Fennie KP; Bova CA; Williams AB
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1():S88-95. PubMed ID: 17133208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A practical method to calibrate self-reported adherence to antiretroviral therapy.
    Liu H; Miller LG; Hays RD; Wagner G; Golin CE; Hu W; Kahn K; Haubrich R; Kaplan AH; Wenger NS
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1():S104-12. PubMed ID: 17133192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple validated measures of adherence indicate high levels of adherence to generic HIV antiretroviral therapy in a resource-limited setting.
    Oyugi JH; Byakika-Tusiime J; Charlebois ED; Kityo C; Mugerwa R; Mugyenyi P; Bangsberg DR
    J Acquir Immune Defic Syndr; 2004 Aug; 36(5):1100-2. PubMed ID: 15247564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment and predictors of antiretroviral adherence in older HIV-infected patients.
    Wutoh AK; Elekwachi O; Clarke-Tasker V; Daftary M; Powell NJ; Campusano G
    J Acquir Immune Defic Syndr; 2003 Jun; 33 Suppl 2():S106-14. PubMed ID: 12853859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measuring HIV treatment adherence in clinical practice.
    Hecht FM
    AIDS Clin Care; 1998 Aug; 10(8):57-9. PubMed ID: 11365682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adherence to antiretroviral therapy by human immunodeficiency virus-infected patients.
    Turner BJ
    J Infect Dis; 2002 May; 185 Suppl 2():S143-51. PubMed ID: 12001036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Responses to a 1 month self-report on adherence to antiretroviral therapy are consistent with electronic data and virological treatment outcome.
    Walsh JC; Mandalia S; Gazzard BG
    AIDS; 2002 Jan; 16(2):269-77. PubMed ID: 11807312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adherence to anti-retroviral therapy and its determinants in HIV/AIDS patients: a review.
    Emamzadeh-Fard S; Fard SE; SeyedAlinaghi S; Paydary K
    Infect Disord Drug Targets; 2012 Oct; 12(5):346-56. PubMed ID: 23017163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A systematic review of pediatric adherence to antiretroviral therapy in low- and middle-income countries.
    Vreeman RC; Wiehe SE; Pearce EC; Nyandiko WM
    Pediatr Infect Dis J; 2008 Aug; 27(8):686-91. PubMed ID: 18574439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Barriers to use of electronic adherence monitoring in an HIV clinic.
    Wendel CS; Mohler MJ; Kroesen K; Ampel NM; Gifford AL; Coons SJ
    Ann Pharmacother; 2001 Sep; 35(9):1010-5. PubMed ID: 11573846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term utility of measuring adherence by self-report compared with pharmacy record in a routine clinic setting.
    Fairley CK; Permana A; Read TR
    HIV Med; 2005 Sep; 6(5):366-9. PubMed ID: 16156886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
    Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
    Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How qualitative methods contribute to understanding combination antiretroviral therapy adherence.
    Sankar A; Golin C; Simoni JM; Luborsky M; Pearson C
    J Acquir Immune Defic Syndr; 2006 Dec; 43 Suppl 1(0 1):S54-68. PubMed ID: 17133205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of pill counts as a facilitator of adherence with antiretroviral therapy in resource limited settings.
    Achieng L; Musangi H; Billingsley K; Onguit S; Ombegoh E; Bryant L; Mwiindi J; Smith N; Keiser P
    PLoS One; 2013; 8(12):e67259. PubMed ID: 24339861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to antiretroviral therapy: are we doing enough?
    Read T; Mijch A; Fairley CK
    Intern Med J; 2003; 33(5-6):254-6. PubMed ID: 12752896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of adherence to antiretroviral medications.
    Paterson DL; Potoski B; Capitano B
    J Acquir Immune Defic Syndr; 2002 Dec; 31 Suppl 3():S103-6. PubMed ID: 12562030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technological methods to measure adherence to antiretroviral therapy and preexposure prophylaxis.
    Garrison LE; Haberer JE
    Curr Opin HIV AIDS; 2017 Sep; 12(5):467-474. PubMed ID: 28590335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple self-report measures of antiretroviral adherence correlated in Sierra Leone, but did they agree?
    Kelly JD; Hubenthal EA; Lurton G; Empson SF; Barrie MB; Kargbo B; Wagner GJ; Giordano TP
    Int J STD AIDS; 2013 Dec; 24(12):931-7. PubMed ID: 23970613
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.